| __timestamp | Arrowhead Pharmaceuticals, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 104381000 |
| Thursday, January 1, 2015 | 57410147 | 100171000 |
| Friday, January 1, 2016 | 41454452 | 102726000 |
| Sunday, January 1, 2017 | 31690298 | 96171000 |
| Monday, January 1, 2018 | 52968505 | 66449000 |
| Tuesday, January 1, 2019 | 81048686 | 42672000 |
| Wednesday, January 1, 2020 | 128874979 | 42534000 |
| Friday, January 1, 2021 | 206342000 | 53311000 |
| Saturday, January 1, 2022 | 297307000 | 82258000 |
| Sunday, January 1, 2023 | 353188000 | 118011000 |
| Monday, January 1, 2024 | 505870000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Arrowhead Pharmaceuticals increased its R&D expenses by an impressive 1,800%, peaking in 2023. In contrast, Celldex Therapeutics saw a more modest increase of around 13% over the same period. Notably, Arrowhead's R&D spending surpassed Celldex's by over 200% in 2023, highlighting its aggressive push towards innovation. However, data for 2024 is missing for Celldex, leaving a gap in the comparison. This trend underscores the dynamic nature of the biotech industry, where strategic investments in R&D can significantly influence a company's market position and future growth.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Merck & Co., Inc. vs Celldex Therapeutics, Inc.
Research and Development Investment: Amgen Inc. vs Celldex Therapeutics, Inc.
argenx SE or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Viatris Inc. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: HUTCHMED (China) Limited vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and Novavax, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and MiMedx Group, Inc.